An Observational Study of Patients With Chronic Liver Disease
Public ClinicalTrials.gov record NCT05744713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
Study identification
- NCT ID
- NCT05744713
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 500,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 18, 2024
- Primary completion
- Dec 30, 2037
- Completion
- Dec 30, 2037
- Last update posted
- Mar 2, 2026
2024 – 2037
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Keck School of Medicine of USC | Los Angeles | California | 90033 | — |
| Stanford Medicine | Redwood City | California | 94063 | — |
| Georgetown Medstar Transplant Institute | Washington D.C. | District of Columbia | 20007 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Columbia University Irving Medical Center/ New York Presbyterian Hospital | New York | New York | 10032 | — |
| Atrium Health Center for Liver Disease and Transplant | Charlotte | North Carolina | 28204 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Temple University - Lewis Katz School of Medicine | Philadelphia | Pennsylvania | 19140 | — |
| Baylor Scott & White Research Institute | Dallas | Texas | 75246 | — |
| Baylor College of Medicine | Houston | Texas | 77021 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05744713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05744713 live on ClinicalTrials.gov.